Related Experiment Video
Updated: Oct 11, 2025

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Association between serum uric acid and carotid atherosclerosis in elderly postmenopausal women: A hospital-based
Xiao-Kang Dong1, Dan Luo2, Wen-Jing Chen1
1Department of Cardiovascular, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Insights
Elevated serum uric acid (SUA) levels are linked to carotid atherosclerosis (CAS) presence and progression. Hormone replacement therapy (HRT) may offer protective benefits against CAS, warranting further investigation.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Endocrinology
Background:
- Carotid atherosclerosis (CAS) is a significant risk factor for stroke, contributing to 20-30% of cases.
- Understanding factors influencing CAS development and progression is crucial for cardiovascular risk management.
Purpose of the Study:
- To investigate the association between serum uric acid (SUA) levels and the presence and progression of carotid atherosclerosis.
- To evaluate the potential role of hormone replacement therapy (HRT) in mitigating CAS.
Main Methods:
- A cohort of 504 patients underwent medical history review, physical examination, carotid ultrasound, and laboratory tests.
- Logistic and multiple linear regression analyses were used to assess the relationship between SUA and CAS.
- The impact of HRT on CAS progression was also examined.
Main Results:
- 81.7% of patients exhibited carotid plaques.
- Higher SUA levels correlated significantly with an increased probability of carotid plaque presence (OR: 2.01).
- Increased SUA was associated with greater plaque score and carotid intima-media thickness progression over 2 years.
- Long-term HRT (≥5 years) was linked to lower SUA, improved lipid profiles, and reduced CAS progression.
Conclusions:
- Serum uric acid levels are significantly associated with the presence and progression of carotid atherosclerosis.
- Hormone replacement therapy may potentially prevent CAS development and slow its progression.
- Further research is needed to confirm the safety and long-term efficacy of HRT for CAS management.
Background:
Carotid atherosclerosis (CAS) is associated with increased cardiovascular risk and implicated in 20-30% of strokes.
Methods:
504 patients were included in this study. The detailed medical history and the results of physical examination, carotid ultrasound examination, and routine laboratory tests were collected. Logistic regression analyses were conducted to analyze the relationship between the SUA and the presence of carotid plaques. And the relationship between SUA and the progression of CAS was analyzed by multiple linear regression. The effect of hormone replacement therapy (HRT) on CAS has also be evaluated.
Results:
412 patients (81.7%) had carotid plaques of different sizes by carotid ultrasound examination. We found a positive association between the level of SUA and the probability of having carotid plaque by univariate logistic regression (OR: 2.01, 95% CI: 1.83-2.19, p = 0.003). At 2 years post-discharge, we found that 1 mg/dL increase in SUA levels was expected to 0.946% increase in plaque score and 0.026 cm increase in carotid intima-media thickness, separately. Moreover, patients treated by long-term HRT (≥5 years) had a lower level of SUA and blood lipid and the less change of plaque score and carotid intima-media thickness than patients without HRT.
Conclusion:
The presence and progression of CAS had significantly positive associations with the level of SUA. And the HRT may have the ability to prevent the presence and progression of CAS. However, the safety and long-term outcome of HRT on CAS should be evaluated in further studies.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism